News & Events related to SECURE

The results of SECURE are now published in the New England Journal of Medicine. SECURE Final recommendations are available here.

The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published in the New England Journal of Medicine.

The polypill reduces cardiovascular mortality by 33% in patients treated after myocardial infarction. More information here.

Recruitment for the SECURE clinical trial is now completed ! 2,499 participants are involved over nearly 100 clinical sites in 7 European countries (see figures below)

The SECURE trial is mentioned in the NY Times article "This Daily Pill Cut Heart Attacks by Half. Why Isn’t Everyone Getting It?", check it out here: https://www.nytimes.com/2019/08/22/health/heart-disease-iran-study.html

SECURE continues to open new centres for the recruitment of patients in the clinical trial. You can find the full lists in the forms related to each country coordinator on the Partners page.

The ESC Congress is the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries.

https://www.escardio.org/Congresses-&-Events/ESC-Congress/

For the second year in a row, CNIC and Ferrer organised a symposium related to SECURE and the polypill entitled "Saving lives beyond adherence". Click here for more details.

And for the fourth year in a row, the SECURE consortium organised a general meeting during the ESC Congress, involving project partners, study investigators and members of the scientific committees.

The ESC Congress is the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries.

https://www.escardio.org/Congresses-&-Events/ESC-Congress/

For the third year in a row, the SECURE consortium organised a general meeting during the ESC Congress, involving project partners, study investigators and members of the scientific committees.

You can download it here: http://www.secure-h2020.eu/modules/downloads/dlc.php?file=17&id=1477671515&sid=17.

In addition to the version in English, the SECURE brochure can now be downloaded in the languages of the 7 countries where the clinical trial takes place, under Project Documentation in SECURE Publications

The SECURE consortium is happy to share that SECURE was awarded the Prize for Best European Cooperation Project from Fundación para el conocimiento Madri+d.

You can find further details at http://www.madrimasd.org/informacionidi/noticias/noticia.asp?id=66858​ (article in Spanish).

You can read about SECURE in all languages of the study on project partners' websites:

• Article from General University Hospital in Prague in Czech
• Article from University Hospital of Besançon in French
• Article from Charité University - Centre for Stroke Research Berlin in German
• Article from Semmelweis University in Hungarian
• Article from Istituto di Ricerche Farmacologiche Mario Negri in Italian
• Article from Medical University of Wroclaw in Polish
• Article in Spanish from Instituto de Investigación Sanitaria San Carlos (Servicio Madrileño de Salud) (11 Noviembre 2015 · ​Proyecto SECURE)

Further details about the study can be found in Polish in an interview of Prof. Ponikowski: publication on Horizon2020 in Poland (Lower Silesia), Patrz w przyszłość. Dolnoślązacy w programie Horyzont 2020, p.30-31

The SECURE trial has been registered and published at the clinicaltrials.gov website.